The role of vitrectomy in the diagnosis and treatment of uveitis_Chinese Journal of Ocular Fundus Diseases

Authors：

 Chang Qing , Jiang Tingting

Department of Ophthalmology, The Eye-ENT Hospital of Fudan University, Shanghai 200031, China;

Corresponding author：

Chang Qing, Email: qngchang@aliyun.com

Keywords：

Uveitis/diagnosis; Uveitis/therapy; Vitrectomy; Editorial

DOI：

10.3760/cma.j.cn511434-20200909-00440

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The etiology of uveitis is complex and the clinical manifestations are varied. Diagnosis and treatment are often very difficult. Detailed medical history, thorough ocular examination and laboratory examination are important basis for diagnosis. In recent years, with the appearance of microincision vitrectomy surgery, it has been applied widely in the diagnosis and treatment of uveitis. It can confirm diagnosis, manage the fundus complications of uveitis, and has certain therapeutic effects. But it is worth emphasizing that the indications of vitrectomy must be strictly controlled. Suitable indications and surgical timing are the key to the effective diagnosis and treatment of uveitis.

Citation： Chang Qing, Jiang Tingting. The role of vitrectomy in the diagnosis and treatment of uveitis. Chinese Journal of Ocular Fundus Diseases, 2020, 36(9): 666-668. doi: 10.3760/cma.j.cn511434-20200909-00440 Copy

1.	Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis[J]. Ophthalmology, 2014, 121(12): 2387-2392. DOI: 10.1016/j.ophtha.2014.07.007.
2.	Oahalou A, Schellekens PAWJF, De Groot-Mijnes JD, et al. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause[J]. Retina, 2014, 34(1): 108-114. DOI: 10.1097/IAE.0b013e31828e6985.
3.	Bansal R, Gupta A, Gupta V, et al. Safety and outcome of microincision vitreous surgery in uveitis[J]. Ocul Immunol Inflamm, 2017, 25(6): 775-784. DOI: 10.3109/09273948.2016.1165259.
4.	Androudi S, Praidou A, Symeonidis C, et al. Safety and efficacy of small incision, sutureless pars plana vitrectomy for patients with posterior segment complications secondary to uveitis[J/OL]. Acta Ophthalmol, 2012(7): 409-410[2012-07-27]. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1755-3768.2011.02258.x. DOI:10.1111/j.1755-3768.2011.02258.x.
5.	Carroll DM, Franklin RM. Vitreous biopsy in uveitis of unknown cause[J]. Retina, 1981, 1(3): 245-251. DOI: 10.1097/00006982-198101030-00022.
6.	Okhravi N, Adamson P, Carroll N, et al. PCR-based evidence of bacterial involvement in eyes with suspected intraocular infection[J]. Invest Ophthalmol Vis Sci, 2000, 41(11): 3474-3479.
7.	Jiang T, Zhao Z, Chang Q. Evaluation of cytologic specimens obtained during experimental vitreous biopsy using B-cell lymphoma line[J]. Eur J Ophthalmol, 2014, 24(6): 911-917. DOI: 10.5301/ejo.5000488.
8.	Sato T, Kinoshita R, Taguchi M, et al. Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies[J/OL]. Medicine (Baltimore), 2018, 97(2): 9491[2018-01-12]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943856/. DOI:10.1097/MD.0000000000009491.
9.	Callaway NF, Gonzalez MA, Yonekawa Y, et al. Outcomes of pars plana vitrectomy for macular hole in patients with uveitis[J]. Retina, 2018, 38(Suppl 1): S41-48. DOI: 10.1097/IAE.0000000000001942.
10.	Rao P, Todorich B, Yonekawa Y, et al. Surgical outcomes of epiretinal membranes in patients with a history of well-controlled preoperative uveitis[J]. Ophthalmol Retina, 2018, 2(3): 192-196. DOI: 10.1016/j.oret.2017.07.002.
11.	Branson SV, McClafferty BR, Kurup SK. Vitrectomy for epiretinal membranes and macular holes in uveitis patients[J]. J Ocul Pharmacol Ther, 2017, 33(4): 298-303. DOI: 10.1089/jop.2016.0142.
12.	Becker M, Davis J. Vitrectomy in the treatment of uveitis[J]. Am J Ophthalmol, 2005, 140(6): 1096-1105. DOI: 10.1016/j.ajo.2005.07.017.
13.	Trittibach P, Koerner F, Sarra GM, et al. Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome[J]. Eye (Lond), 2006, 20(2): 184-190. DOI: 10.1038/sj.eye.6701845.
14.	Henry CR, Becker MD, Yang Y, et al. Pars plana vitrectomy for the treatment of uveitis[J]. Am J Ophthalmol, 2018, 190: 142-149. DOI: 10.1016/j.ajo.2018.03.031.
15.	Quinones K, Choi JY, Yilmaz T, et al. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study[J]. Ocul Immunol Inflamm, 2010, 18(5): 411-417. DOI: 10.3109/09273948.2010.501132.

1. Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis[J]. Ophthalmology, 2014, 121(12): 2387-2392. DOI: 10.1016/j.ophtha.2014.07.007.
2. Oahalou A, Schellekens PAWJF, De Groot-Mijnes JD, et al. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause[J]. Retina, 2014, 34(1): 108-114. DOI: 10.1097/IAE.0b013e31828e6985.
3. Bansal R, Gupta A, Gupta V, et al. Safety and outcome of microincision vitreous surgery in uveitis[J]. Ocul Immunol Inflamm, 2017, 25(6): 775-784. DOI: 10.3109/09273948.2016.1165259.
4. Androudi S, Praidou A, Symeonidis C, et al. Safety and efficacy of small incision, sutureless pars plana vitrectomy for patients with posterior segment complications secondary to uveitis[J/OL]. Acta Ophthalmol, 2012(7): 409-410[2012-07-27]. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1755-3768.2011.02258.x. DOI:10.1111/j.1755-3768.2011.02258.x.
5. Carroll DM, Franklin RM. Vitreous biopsy in uveitis of unknown cause[J]. Retina, 1981, 1(3): 245-251. DOI: 10.1097/00006982-198101030-00022.
6. Okhravi N, Adamson P, Carroll N, et al. PCR-based evidence of bacterial involvement in eyes with suspected intraocular infection[J]. Invest Ophthalmol Vis Sci, 2000, 41(11): 3474-3479.
7. Jiang T, Zhao Z, Chang Q. Evaluation of cytologic specimens obtained during experimental vitreous biopsy using B-cell lymphoma line[J]. Eur J Ophthalmol, 2014, 24(6): 911-917. DOI: 10.5301/ejo.5000488.
8. Sato T, Kinoshita R, Taguchi M, et al. Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies[J/OL]. Medicine (Baltimore), 2018, 97(2): 9491[2018-01-12]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943856/. DOI:10.1097/MD.0000000000009491.
9. Callaway NF, Gonzalez MA, Yonekawa Y, et al. Outcomes of pars plana vitrectomy for macular hole in patients with uveitis[J]. Retina, 2018, 38(Suppl 1): S41-48. DOI: 10.1097/IAE.0000000000001942.
10. Rao P, Todorich B, Yonekawa Y, et al. Surgical outcomes of epiretinal membranes in patients with a history of well-controlled preoperative uveitis[J]. Ophthalmol Retina, 2018, 2(3): 192-196. DOI: 10.1016/j.oret.2017.07.002.
11. Branson SV, McClafferty BR, Kurup SK. Vitrectomy for epiretinal membranes and macular holes in uveitis patients[J]. J Ocul Pharmacol Ther, 2017, 33(4): 298-303. DOI: 10.1089/jop.2016.0142.
12. Becker M, Davis J. Vitrectomy in the treatment of uveitis[J]. Am J Ophthalmol, 2005, 140(6): 1096-1105. DOI: 10.1016/j.ajo.2005.07.017.
13. Trittibach P, Koerner F, Sarra GM, et al. Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome[J]. Eye (Lond), 2006, 20(2): 184-190. DOI: 10.1038/sj.eye.6701845.
14. Henry CR, Becker MD, Yang Y, et al. Pars plana vitrectomy for the treatment of uveitis[J]. Am J Ophthalmol, 2018, 190: 142-149. DOI: 10.1016/j.ajo.2018.03.031.
15. Quinones K, Choi JY, Yilmaz T, et al. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study[J]. Ocul Immunol Inflamm, 2010, 18(5): 411-417. DOI: 10.3109/09273948.2010.501132.

Chinese Journal of Ocular Fundus Diseases

The role of vitrectomy in the diagnosis and treatment of uveitis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content